Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide in Nelson's Syndrome
NCT01617733Phase 2Terminated
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Mar 2011
- Primary completion
- Aug 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pasireotide LAR in Nelson's syndrome, sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Mar 2011; status: terminated.
02
Drugs
pasireotide LAR
03
Conditions
Nelson's syndrome
Beyond the preview
Go deeper on NCT01617733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617733.